These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
860 related items for PubMed ID: 11230751
21. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Bizollon T, Palazzo U, Ducerf C, Chevallier M, Elliott M, Baulieux J, Pouyet M, Trepo C. Hepatology; 1997 Aug; 26(2):500-4. PubMed ID: 9252166 [Abstract] [Full Text] [Related]
22. What to do when standard therapy fails. Buti M, Esteban R. Forum (Genova); 2000 Aug; 10(1):63-9. PubMed ID: 10717258 [Abstract] [Full Text] [Related]
23. Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNA. Shiratori Y, Yokosuka O, Nakata R, Ihori M, Hirota K, Katamoto T, Unuma T, Okano K, Ikeda Y, Hirano M, Kawase T, Takano S, Matsumoto K, Ohashi Y, Omata M. Hepatology; 1999 May; 29(5):1573-80. PubMed ID: 10216145 [Abstract] [Full Text] [Related]
24. [Early prediction of lack of response to treatment with interferon and interferon plus ribavirin using biochemical and virological criteria in patients with chronic hepatitis C]. Olaso V, Córdoba J, Lòpez Viedma B, Siles MS, Molina JM, Prieto M, Baum I, Gobernado M, Berenguer J. Rev Esp Quimioter; 1999 Sep; 12(3):220-8. PubMed ID: 10878512 [Abstract] [Full Text] [Related]
25. Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial. Fontana RJ, Israel J, LeClair P, Banner BF, Tortorelli K, Grace N, Levine RA, Fiarman G, Thiim M, Tavill AS, Bonkovsky HL. Hepatology; 2000 Mar; 31(3):730-6. PubMed ID: 10706565 [Abstract] [Full Text] [Related]
26. Advances in the treatment of hepatitis C. Lawrence SP. Adv Intern Med; 2000 Mar; 45():65-105. PubMed ID: 10635046 [Abstract] [Full Text] [Related]
27. Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy. Larghi A, Tagger A, Crosignani A, Ribero ML, Bruno S, Portera G, Battezzati PM, Maggioni M, Fasola M, Zuin M, Podda M. J Med Virol; 1998 May; 55(1):7-11. PubMed ID: 9580879 [Abstract] [Full Text] [Related]
28. An updated follow-up of chronic hepatitis C after three decades of observation in pediatric patients cured of malignancy. Cesaro S, Bortolotti F, Petris MG, Brugiolo A, Guido M, Carli M. Pediatr Blood Cancer; 2010 Jul 15; 55(1):108-12. PubMed ID: 20127849 [Abstract] [Full Text] [Related]
29. Therapy of hepatitis C: alpha interferon and ribavirin. Reichard O, Schvarcz R, Weiland O. Hepatology; 1997 Sep 15; 26(3 Suppl 1):108S-111S. PubMed ID: 9305674 [Abstract] [Full Text] [Related]
30. Combination therapy with interferon and ribavirin for chronic hepatitis C infection in beta-thalassaemia major. Saffar MJ, Saffar H, Khalilian AR, Naqshvar F. East Mediterr Health J; 2009 Sep 15; 15(4):785-91. PubMed ID: 20187529 [Abstract] [Full Text] [Related]
31. Antiviral therapy for chronic hepatitis C viral infection. Sherlock S. J Hepatol; 1995 Sep 15; 23 Suppl 2():3-7. PubMed ID: 8720286 [Abstract] [Full Text] [Related]
32. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial. Di Bisceglie AM, Bonkovsky HL, Chopra S, Flamm S, Reddy RK, Grace N, Killenberg P, Hunt C, Tamburro C, Tavill AS, Ferguson R, Krawitt E, Banner B, Bacon BR. Hepatology; 2000 Jul 15; 32(1):135-8. PubMed ID: 10869301 [Abstract] [Full Text] [Related]
33. [The effect of iron depletion on the response to interferon treatment in patients with chronic hepatitis C. Pilot study]. Ortiz V, Olaso V, López Viedma B, Córdoba J, Molina JM, Lainez B, Pastor M, Berenguer J. Gastroenterol Hepatol; 1999 Mar 15; 22(3):122-6. PubMed ID: 10228321 [Abstract] [Full Text] [Related]
34. Genetic polymorphism of low-density lipoprotein receptor did not affect treatment outcome of chronic hepatitis C genotype 3. Tanwandee T, Pithukpakorn M, Vipatakul N, Charatcharoenwitthaya P, Chainuvati S, Nimanong S, Prachayakul V, Pongprasobchai S, Manatsathit S, Leelakusolvong S, Pausawasdi N, Kachintorn U, Limwongse C, Udompunturak S. J Med Assoc Thai; 2011 Feb 15; 94 Suppl 1():S147-53. PubMed ID: 21721440 [Abstract] [Full Text] [Related]
36. Interferon and ribavirin versus interferon and amantadine in interferon nonresponders with chronic hepatitis C. Khalili M, Denham C, Perrillo R. Am J Gastroenterol; 2000 May 15; 95(5):1284-9. PubMed ID: 10811340 [Abstract] [Full Text] [Related]